Valuation: Moderna, Inc.

Market Cap 55.45B 940B 47.52B 44.46B 40.64B 76.7B 5,309B 77.51B 526B 205B 2,666B 208B 204B 8,821B P/E 2026 *
-16.2x
P/E 2027 * -28.5x
Enterprise Value 51.8B 878B 44.39B 41.53B 37.97B 71.65B 4,960B 72.41B 491B 191B 2,491B 194B 190B 8,241B EV / Sales 2026 *
24.6x
EV / Sales 2027 * 21.7x
Free-Float
92.68%
Yield 2026 *
-
Yield 2027 * -
1 day-3.36%
1 week+118.43%
Current month+145.60%
1 month+150.26%
3 months+188.95%
6 months+166.29%
Current year+346.33%
1 week 1,505
Extreme 1505
2,975.59
1 month 932
Extreme 932
2,975.59
Current year 555
Extreme 555
2,975.59
1 year 414
Extreme 414
2,975.59
3 years 414
Extreme 414
2,975.59
5 years 414
Extreme 414
9,246.09
10 years 254.3
Extreme 254.3
9,913.99
Manager TitleAgeSince
Chief Executive Officer 54 2011-02-28
Director of Finance/CFO 49 2022-09-05
President 50 2024-10-31
Director TitleAgeSince
Chairman 63 2012-01-31
Director/Board Member 54 2011-02-28
Director/Board Member 69 2019-12-10
Change 5-day change 1-year change 3-year change Capi.($)
-3.36%+118.43% - - 55.45B
-0.66%+2.80%+40.55%-0.33% 82.73B
-4.30%+115.47%+412.13%+23.29% 55.45B
+2.68%+10.02%-19.76%-34.08% 57.94B
+1.42%+1.61%-0.67%+34.08% 52.57B
+1.14%+2.39%+10.70%+172.40% 48.94B
+0.62%+4.29%+56.57%-16.88% 32.23B
+0.13%+3.63%+50.49%+99.25% 25.94B
+0.60%+3.57%+0.15%+196.15% 22.1B
+2.21%-0.60%+59.13%+108.58% 16.55B
Average +0.72%+17.75%+67.70%+64.72% 43.83B
Weighted average by Cap. +0.55%+22.00%+75.21%+44.83%

Financials

2026 *2027 *
Net sales 2.11B 35.72B 1.81B 1.69B 1.54B 2.91B 202B 2.94B 19.98B 7.77B 101B 7.91B 7.74B 335B 2.46B 41.67B 2.11B 1.97B 1.8B 3.4B 235B 3.44B 23.31B 9.06B 118B 9.23B 9.03B 391B
Net income -3.38B -57.29B -2.9B -2.71B -2.48B -4.67B -324B -4.72B -32.06B -12.46B -162B -12.69B -12.41B -538B -1.9B -32.14B -1.62B -1.52B -1.39B -2.62B -181B -2.65B -17.98B -6.99B -91.13B -7.12B -6.96B -302B
Net Debt -3.65B -61.87B -3.13B -2.93B -2.67B -5.05B -349B -5.1B -34.62B -13.46B -175B -13.7B -13.4B -581B -2.19B -37.2B -1.88B -1.76B -1.61B -3.03B -210B -3.07B -20.81B -8.09B -105B -8.24B -8.06B -349B
Logo Moderna, Inc.
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (96.1%); - revenue from collaboration agreements (1.5%); - revenue from royalties and licensing (1.3%); - revenue from grants (1.1%). At the end of 2024, the group's portfolio comprises 37 products in clinical development, of which 10 in phase I, 18 in phase II and 9 in phase III, 3 products in preclinical development, and 4 products in commercial phase. Net sales are distributed geographically as follows: the United States (55.1%), Europe (18.5%) and other (26.4%).
Employees
4,700
Date Price Change Volume
26-08-24 MX$2,370.00 -3.36% 874
26-08-21 MX$2,452.50 +8.46% 3,750
26-08-20 MX$2,261.21 -22.75% 3,998
26-08-19 MX$2,927.17 +171.54% 10,102
26-08-18 MX$1,078.00 -0.65% 42
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
138.89USD
Average target price
95.67USD
Spread / Average Target
-31.12%

Quarterly revenue - Rate of surprise